1. Home
  2. VCYT vs CNS Comparison

VCYT vs CNS Comparison

Compare VCYT & CNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veracyte Inc.

VCYT

Veracyte Inc.

HOLD

Current Price

$43.60

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Logo Cohen & Steers Inc

CNS

Cohen & Steers Inc

HOLD

Current Price

$61.01

Market Cap

3.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VCYT
CNS
Founded
2006
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.1B
IPO Year
2013
2004

Fundamental Metrics

Financial Performance
Metric
VCYT
CNS
Price
$43.60
$61.01
Analyst Decision
Strong Buy
Hold
Analyst Count
8
2
Target Price
$45.38
$72.50
AVG Volume (30 Days)
959.1K
547.7K
Earning Date
11-04-2025
01-21-2026
Dividend Yield
N/A
4.07%
EPS Growth
N/A
18.87
EPS
0.38
3.19
Revenue
$495,141,000.00
$552,096,000.00
Revenue This Year
$16.02
$8.26
Revenue Next Year
$10.74
$10.55
P/E Ratio
$114.90
$19.13
Revenue Growth
16.41
11.13
52 Week Low
$22.61
$58.80
52 Week High
$50.71
$102.17

Technical Indicators

Market Signals
Indicator
VCYT
CNS
Relative Strength Index (RSI) 51.98 39.97
Support Level $45.68 $59.81
Resistance Level $48.10 $64.43
Average True Range (ATR) 2.25 1.65
MACD -0.41 0.08
Stochastic Oscillator 41.56 39.11

Price Performance

Historical Comparison
VCYT
CNS

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

About CNS Cohen & Steers Inc

Cohen & Steers is a niche asset manager concentrating on real estate securities. The firm invests mainly in the equity shares of real estate investment trusts, with holdings in domestic and international real estate securities accounting for around two thirds of its $90.9 billion in managed assets at the end of September 2025. Cohen & Steers also manages portfolios dedicated to preferred securities, utilities stocks, and other high-yield offerings. The firm's distribution is balanced among its closed-end funds, open-end funds, and institutional accounts. During the past four calendar quarters, the company garnered 39% (26%) of its managed assets (base management fees) from institutional clients, 48% (54%) from open-end funds, and 13% (20%) from closed-end funds.

Share on Social Networks: